
Conference Coverage
about 13 hours ago
KRd Improves Progression in Newly Diagnosed Patients With Myelomaabout 14 hours ago
Odronextamab Plus CHOP Shows Early Efficacy in DLBCLabout 22 hours ago
Families of Children With ALL Face Catastrophic Financial Toxicityabout 1 month ago
What Patients With Cancer Should Know About Radiation Side Effectsabout 1 month ago
Hernexeos Effective in HER2-Mutated NSCLCabout 1 month ago
Insights Into Advancing Care and Research in Hairy Cell LeukemiaLatest Content

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Odronextamab Plus CHOP Shows Early Efficacy in DLBCL

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica

Shorts






Podcasts
Videos
All News

For pediatric and young adult patients with B-cell acute lymphoblastic leukemia, removal of total body irradiation did not compromise efficacy.

Among children receiving chemotherapy for acute lymphoblastic leukemia, 30% of their families developed catastrophic financial toxicity.

CURE honored four individuals whose compassion and leadership shaped support education and empowerment for people living with blood cancers.

I believe time to be a gift, and as such, my sister was gifted more than a decade despite a terminal illness, and I do have gratitude for that.

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

Facing my cancer diagnosis, I learned it’s okay not to be okay and found comfort in laughter, honesty, and the support of loved ones.

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

TARA-002 may offer meaningful benefits for patients with non-muscle invasive bladder cancer, including those who have limited treatment options.

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

The FDA approved Breyanzi for adults with relapsed or refractory marginal zone lymphoma who received at least two prior lines of systemic therapy.

I’ve lived with stage 4 breast cancer for 11 years, and each day brings gratitude for my family, my oncologist, and the care that keeps me going.

Stage 1 myelofibrosis is a manageable early-stage blood cancer that requires ongoing monitoring and personalized care to support long-term health.

As part of her journey with stage 3 inflammatory breast cancer, Lindsey Gunter experienced chemotherapy side effects so severe that she was unable to walk.

I experienced acute myeloid leukemia twice. Had it not been for follow up appointments I would not be here.

















